Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × lavender oil × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Skin Neoplasms 1 Neoplasms 1 Melanoma 1 Hematopoietic and Lymphatic System Neoplasm 1

Interventions

pembrolizumab 155 Gemcitabine 139 Paclitaxel 130 Carboplatin 118 Bevacizumab 111 Surveys and Questionnaires 99 Docetaxel 96 Cyclophosphamide 96 Cisplatin 96 Exercise 90 Blood Specimen Collection 88 Nivolumab 85 Fluorouracil 75 Capecitabine 74 Dexamethasone 71 Radiotherapy 69 Irinotecan 63 Standard of Care 59 Pemetrexed 59 Oxaliplatin 57 Drug Therapy 55 Leucovorin 54 Cetuximab 49 Erlotinib Hydrochloride 46 atezolizumab 45 Sorafenib 44 Interviews as Topic 43 Doxorubicin 42 Ipilimumab 38 130-nm albumin-bound paclitaxel 38

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02670941 2019-01-24

Aromatherapy for Chemotherapy-induced Symptoms

University of Rochester

Phase EARLY_PHASE1 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡